Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma
Maryam Soleimani, Marisa Thi, Sajjad Janfaza, Gizem Ozcan, Sylwia Mazurek, Guliz Ozgun, Corinne Maurice-Dror, Bernhard Eigl, Kim Chi, Christian Kollmannsberger, Lucia Nappi
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRenal cell carcinoma treatment · Extracellular vesicles in disease · Bladder and Urothelial Cancer Treatments
Correction to: Scientific Reports 10.1038/s41598-024-59337-4, published online 13 April 2024
The Supplementary Information published with this Article contained an error. In Supplementary Figure S1, panel f was a duplication of panel e. The original Supplementary Information file is provided below.
This error has now been corrected in the Supplementary Information file that accompanies the original Article.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Information.